Company engages Standards Council of Canada; targets ISO 15189 accreditation for early 2026Vancouver, British Columbia--(Newsfile Corp. - December 23, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: ...

No one's crossed the finishing line yet, but drug developer Nyrada is leading the Great Biotech Regatta of 2025 with close to ...

Singlera Genomics, a company focused on the development and application of novel DNA methylation technologies to genetic ...

An update from BioMark Diagnostics ( ($TSE:BUX) ) is now available. BioMark Diagnostics Inc. has begun the process to obtain ISO 15189 ...

Azimut is concurrently advancing two other discoveries on the adjacent Wabamisk Property: the Fortin Antimony-Gold Zone and the Rosa Gold Zone (see press releases dated October 23, 2025 (iii) and ...

Discover how artificial intelligence is transforming influenza vaccine development, accelerating timelines and improving ...

The insights gained from this study not only validate OVCAR3 as a representative model for HGSOC, but also provide a foundation for developing ...

Researchers created the most detailed maps yet of the genome’s three-dimensional organization using human stem cells and ...

The US Food and Drug Administration cleared a number of molecular tests and immunoassays, as well as a clinical chemistry and a cellular deformation test.

Artificial intelligence-supported cell imaging could help laboratories to set defensible quality thresholds for living ...

The diagnostic armamentarium for solid tumors is evolving rapidly, redefining how we detect, stage, stratify, monitor, and ultimately treat cancer. This ...